Arkolith/Insider Trading/SLRX/Form 4

Burleson Tess

DirectorSalarius Pharmaceuticals, Inc. (SLRX) · full profile →Form 4 · filed Jun 8, 2022
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2022Buy(P)28K$0.18$5K32K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001615219-22-000101) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML